A new study by researchers from Marshall University and the University of Missouri highlights how exosomes—tiny vesicles ...

Researchers at The University of Texas Health Science Center at San Antonio have discovered a way to delay or even block ...

For decades microtubule-targeting agents (MTAs) have been a cornerstone of cancer treatment regimens and continue to be heavily employed as backbone chemotherapy in combination with new targeted ...

Rakovina will present two abstracts at the meeting, the first: Discovery of novel PARP1-selective inhibitors for treatment of brain tumors using artificial intelligence , explores the use of ...

CNS Pharmaceuticals (CNSP) announced the primary analysis of its clinical trial evaluating Berubicin, the first anthracycline demonstrated to ...

Mia Love, the first Black Republican woman elected to Congress, died three years after being diagnosed with glioblastoma, a ...

Learn how nanoparticles cross the blood-brain barrier (BBB) and explore their potential in treating neurological disorders ...

In an early-stage clinical trial, the therapy nearly doubled the expected survival time of young patients. Still, experts ...

A novel blood test evaluating protease activity identified 85% of early-stage pancreatic cancer samples. The test could be used for other cancer types, as well. A novel, rapid blood test ...